Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative

被引：13

作者：

Bessone, Fernando ^{[1
]}

Hernandez, Nelia ^{[2
]}

Davalos, Milagros ^{[3
]}

Parana, Raymundo ^{[4
]}

Schinoni, Maria I. ^{[4
]}

Lizarzabal, Maribel ^{[5
]}

Kershenobich, David ^{[6
]}

Loaeza, Aurora ^{[6
]}

Arrese, Marco ^{[7
]}

Chirino, Ruby A. ^{[8
]}

Mendez-Sanchez, Nahum ^{[9
]}

Fay, Fabian ^{[10
]}

Bruguera, Miguel ^{[11
]}

Stephens, Camilla ^{[12
,13
]}

Lucena, Maria I. ^{[12
,13
]}

Andrade, Raul J. ^{[12
,13
]}

机构：

[1] Univ Nacl Rosario, Fac Ciencias Med, Serv Gastroenterol & Hepatol, Hosp Prov Centenario, RA-2000 Rosario, Santa Fe, Argentina

[2] Univ Republica, Fac Med, Hosp Clin, Montevideo, Uruguay

[3] Hosp Nacl Edgardo Rebagliati Martins, Unidad Gastroenterol & Hepatol, Lima, Peru

[4] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador De Bahia, Brazil

[5] Hosp Univ Maracaibo, Ctr Reg Referencia Gastroenterol Endoscopia & Hep, Maracaibo, Venezuela

[6] Hosp Gen Mexico City, Mexico City, DF, Mexico

[7] Univ Catolica Chile, Fac Med Pontificia, Dept Gastroenterol, Santiago, Chile

[8] Hosp Angeles Pedregal, Mexico City, DF, Mexico

[9] Fdn Clin Med Sur, Unidad Hepatol, Dept Invest Biomed, Mexico City, DF, Mexico

[10] Ctr Diagnost Med CIBIC, Rosario, Santa Fe, Argentina

[11] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain

[12] Univ Malaga, Fac Med, Hosp Univ Virgen de la Victoria, Unidad Hepatol,Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain

[13] Univ Malaga, Fac Med, Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA,Serv Farmacol Cli, E-29071 Malaga, Spain

来源：

ANNALS OF HEPATOLOGY | 2012年 / 11卷 / 04期

关键词：

HLA CLASS-I; HEPATOTOXICITY; SUSCEPTIBILITY; GENOTYPE; DAMAGE;

D O I：

10.1016/S1665-2681(19)31469-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：544 / 549

页数：6

共 21 条

[1]

Accuracy of hepatic adverse drug reaction reporting in one English health region [J].

Aithal, GP ;

Rawlins, MD ;

Day, CP .

BRITISH MEDICAL JOURNAL, 1999, 319 (7224) :1541-1541

[2]

Aithal GP, 2011, CLIN PHARMACOL THER, V55, P683

[3]

The natural history of histologically proved drug induced liver disease [J].

Aithal, PG ;

Day, CP .

GUT, 1999, 44 (05) :731-735

[4]

Andrade RJ, 2009, PHARMACOGENOMICS, V10, P1467, DOI [10.2217/pgs.09.111, 10.2217/PGS.09.111]

[5]

Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].

Andrade, RJ ;

Lucena, MI ;

Fernández, MC ;

Pelaez, G ;

Pachkoria, K ;

García-Ruiz, E ;

García-Munoz, B ;

González-Grande, R ;

Pizarro, A ;

Durán, JA ;

Jiménez, M ;

Rodrigo, L ;

Romero-Gomez, M ;

Navarro, JM ;

Planas, R ;

Costa, J ;

Borras, A ;

Soler, A ;

Salmerón, J ;

Martin-Vivaldi, R .

GASTROENTEROLOGY, 2005, 129 (02) :512-521

[6]

DICLOFENAC-ASSOCIATED HEPATOTOXICITY - ANALYSIS OF 180 CASES REPORTED TO THE FOOD-AND-DRUG-ADMINISTRATION AS ADVERSE REACTIONS [J].

BANKS, AT ;

ZIMMERMAN, HJ ;

ISHAK, KG ;

HARTER, JG .

HEPATOLOGY, 1995, 22 (03) :820-827

[7]

Bessone F, 2000, Gastroenterol Hepatol, V23, P200

[8]

Bessone Fernando, 2010, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V9, P355

[9]

Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? [J].

Bessone, Fernando .

WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (45) :5651-5661

[10]

Burroughs VJ, 2002, J NATL MED ASSOC, V94, P1

← 1 2 3 →